Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis

被引：0
|
作者：
April W. Armstrong
Ahmed M. Soliman
Keith A. Betts
Yan Wang
Yawen Gao
Luis Puig
Matthias Augustin
机构：
[1] University of Southern California,Department of Dermatology, Keck School of Medicine
[2] AbbVie,Department of Dermatology
[3] Inc.,Health Care Research in Dermatology and Nursing
[4] Analysis Group,undefined
[5] Inc.,undefined
[6] Hospital de la Santa Creu i Sant Pau–Universitat Autònoma de Barcelona,undefined
[7] University Medical Center Hamburg-Eppendorf,undefined
来源：
Dermatology and Therapy | 2021年 / 11卷
关键词：
Biologic therapies; Network meta-analysis; Plaque psoriasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：885 / 905
页数：20
相关论文
共 50 条
  • [31] Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials
    Reich, K.
    Burden, A. D.
    Eaton, J. N.
    Hawkins, N. S.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (01) : 179 - 188
  • [32] Efficacy of several biological therapies for treating moderate to severe psoriasis: A network meta-analysis
    Geng, Wenjun
    Zhao, Jianhua
    Fu, Jixing
    Zhang, Huamin
    Qiao, Shaohua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 5085 - 5095
  • [33] Letter to the editor concerning the article: "Comparative safety and benefit-risk profile of biologics and oral treatments for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data"
    Pettitt, Dan
    Plotnick, Michael
    Miller, Lloyd S.
    Berlin, Jesse A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (05) : E305 - E306
  • [34] Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta-analysis
    Hu, Caixia
    Han, Xiaomei
    Cui, Yu
    Zhang, Yan
    Cheng, Yi
    SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (08)
  • [35] Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis
    Leman, J.
    Burden, A. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : 12 - 20
  • [36] Efficacy of risankizumab in moderate-to-severe plaque psoriasis by baseline characteristics and prior therapies
    Strober, B.
    Valdecantos, W.
    Zhan, T.
    Lambert, J.
    Menter, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 42 - 43
  • [37] Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Janet Pope
    Ruta Sawant
    Namita Tundia
    Ella X. Du
    Cynthia Z. Qi
    Yan Song
    Patrick Tang
    Keith A. Betts
    Advances in Therapy, 2020, 37 : 2356 - 2372
  • [38] Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Pope, Janet
    Sawant, Ruta
    Tundia, Namita
    Du, Ella X.
    Qi, Cynthia Z.
    Song, Yan
    Tang, Patrick
    Betts, Keith A.
    ADVANCES IN THERAPY, 2020, 37 (05) : 2356 - 2372
  • [39] Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis
    Singh, Siddharth
    Murad, M. Hassan
    Fumery, Mathurin
    Sedano, Rocio
    Jairath, Vipul
    Panaccione, Remo
    Sandborn, William J.
    Ma, Christopher
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 1002 - 1014
  • [40] Efficacy and safety of tofacitinib for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials
    Kuo, C. -M.
    Tung, T. -H.
    Wang, S. -H.
    Chi, C. -C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 355 - 362
12345